Share Name Share Symbol Market Type Share ISIN Share Description
Abcam Plc LSE:ABC London Ordinary Share GB00B6774699 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -18.00 -1.5% 1,180.00 1,179.00 1,180.00 1,200.00 1,162.00 1,198.00 638,526 16:29:08
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 259.9 56.4 22.0 53.6 2,432

Abcam Share Discussion Threads

Showing 801 to 824 of 1025 messages
Chat Pages: 41  40  39  38  37  36  35  34  33  32  31  30  Older
DateSubjectAuthorDiscuss
22/2/2015
11:09
results a fortnight tomorrow - been very firm over the past few weeks imo. CR
cockneyrebel
16/2/2015
19:38
Not a "tip" rich! Just shared info. We don't do CGT here :-) It looks as if the "ABC is ex-growth" story didn't gain any traction. No chance for my Mum to increase :-( apad
apad
16/2/2015
19:29
Apad I have CGT probs just now preventing me from releasing any cash for top ups.... Thanks for the tip though.... Rich
richscotsman
12/2/2015
21:05
I've never seen a share price go round in a circle like that. Is that a good sign?
trident5
12/2/2015
20:58
Chart looking good here APAD, imo: free stock charts from uk.advfn.com
cockneyrebel
10/2/2015
22:18
I nearly bought Bioventix on the Plus market, and again when it joined AIM, tri... Sort of feeling I've missed the boat :-) I've a small holding in SRT, showing a tiny profit, but I'm not convinced it can withstand lower-priced competition and big competitors. Excellent, dedicated company, though, but it reminds me too much of Psion! I hope I'm wrong - the frighteningly knowledgeable folks on the Bulletin Board deserve it :-) apad
apad
10/2/2015
21:58
Hi Apad good to see it's back to 140. I guess once it breaks through a 10k barrier it then bobs around under and over that mark before consistently moving away. I bought some Bioventix a while back at round 650 and have topped up a bit. I don't really like companies I don't understand. And I don't really understand Bioventix. But judging by the margins it's got a lot of pricing power, sales seem to be growing strongly and the market cap is small. And biotech seems a promising place to be just now. My intention is that it is a long term hold. You still holding SRT? That could get very interesting over the next few months.
trident5
10/2/2015
21:27
Back to 140k rich (I must get a life). I guess the ex-growth story isn't going to drive the share price down enough to get a good buying opportunity. My Mum wants more :-) Did you ever look at Bioventix? apad
apad
02/2/2015
22:11
Have they also got russian problems? Oxford Instruments warns on profits due to tightened Russia sanctions Link to Abcams offical distributor in russia hxxp://www.almabion.ru/ (Abcam is their top supplier hxxp://www.pivotalscientific.com/distributors-europe/listing/almabion Not looking good
christmasworker
02/2/2015
22:11
Have ABC also got russian problems? Oxford Instruments warns on profits due to tightened Russia sanctions Link to Abcams offical distributor in russia hxxp://www.almabion.ru/ (Abcam is their top supplier hxxp://www.pivotalscientific.com/distributors-europe/listing/almabion Not looking good
christmasworker
01/2/2015
23:31
Telegraph Jim Slater says Avoid ABC Have TEF instead says big jim In January stockbroker Peel Hunt recommended Telford Homes as one of their 17 top growth shares for 2015 with a target price of 420p. I bought a few more at 352p, having tipped them in August at 288p. The shares traded this week at 355p.
dlku
31/1/2015
10:42
Slater in the Telegraph today - with any luck that should drive the share price down for those who are looking for an entry point. apad  . .R01;and some can be disastrous Other Aim shares that are favourites of veteran IHT investors are Young & Co’s Brewery, Advanced Medical Solutions and Abcam. All three are good sound companies but it seems to me that their share prices are living on the memory of their excellent past growth. Nowadays their p/e ratios are in or around the 20s with only single-digit earnings growth forecast. They are not for me because the slightest upset in their earnings growth could cause a major setback in their shares.
apad
29/1/2015
12:57
350p nailed on chart I'm a supporter of ABC but realistically... £870m seems an awfully high valuation did broker downgrade after buying firefly - not expected to return a profit for 3 or 4 years
dlku
28/1/2015
13:05
350p looks nailed on that chart market nervous ahead of Fed
dlku
26/1/2015
19:31
Apad You beat me to it..... I will see what I can do but might take me a few days.... Busy with work at the moment so no time to spare! Rick
richscotsman
26/1/2015
19:03
rich, translation needed. Sounds very impressive to someone with no specialist knowledge - multiplexing! apad www.genomeweb.com/microarrays-multiplexing/abcam-gains-multiplexing-mirna-assays-firefly-buy-sees-opportunities
apad
26/1/2015
17:43
Albany30 - time to eat your words? I've never been long or short QPP so get your facts right? Great day here tho - pull back was just noise imo :-) CR
cockneyrebel
26/1/2015
17:39
Albany - wish I'd shorted it.
trident5
23/1/2015
16:35
Crazy pull back on Shore's note this week but I think it' all nonsense - waiting for these to rally back up when sense prevails. CR
cockneyrebel
23/1/2015
08:10
Heading north from here??
js_trader
22/1/2015
17:43
Abcam is featured in today's ADVFN podcast. To listen to the podcast click here> http://bit.ly/ADVFN0113 In today's podcast: - Chris Oil, financial writer and city investor will be chatting about a well known name who could be back in fashion. Chris on Twitter is @ChrisOil - And Rodney Hobson, a financial speaker, writer and author of investment books including Shares Made Simple, the beginner's guide to the stock market. Rodney on Twitter is @RodneyHobson - The micro and macro news - Plus the broker forecasts Every Tuesday is Ten Bagger Tuesday on the podcast. If you know of a stock, whose share price has the potential to increase ten fold, just click the link below. Ten Bagger Tuesday (All it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast). Once a week, on a Friday, I feature a tip from a listener to this podcast, if you'd like to suggest a stock click the link below: Suggest a stock (Again all it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast). You can subscribe to this podcast in iTunes by clicking HERE To follow me on Twitter click HERE As a listener to the ADVFN podcast you can take advantage of some exclusive first year discounts on popular subscriptions: Bronze - £50 (normally £73.82/year) Silver - £145 (normally £173.71/year) Level 2 - £350 (normally £472.94/year) Call 0207 0700 961 and ask for the ADVFN Podcast discount to take advantage of these reduced rates or just CLICK HERE for more information. Please DO NOT buy any stock recommended in this podcast basely solely on what you hear. The opinions in this podcasts are just that, opinions. Please do you own research before investing. Justin    
jeffcranbounre
22/1/2015
17:24
Abcam may well have it's ups and downs.... Look at the chart and it is mainly up. They do however have unique capability in a market which has long term grant funding... For me this is a safer bet in a downturn than gold but also okay generally. The fact that the bod take a view of future markets and invest in a company that they can add value to is positive. What may cost in the short term is wise in the long term. They could easily have made no progress by cutting overheads to a minimum in search of short term share price reward. The acquisition is further evidence of bod that understands the future market and can close a deal. Strip out currency and the growth is stunning. If you look forward then those currency trends may well reverse.
richscotsman
22/1/2015
11:11
Have they also got russian problems? Oxford Instruments warns on profits due to tightened Russia sanctions Link to Abcams offical distributor in russia hxxp://www.almabion.ru/ (Abcam is their top supplier hxxp://www.pivotalscientific.com/distributors-europe/listing/almabion Not looking good
christmasworker
22/1/2015
09:17
CW Singer said sell back in July, when the price was 360. I learned a long time ago that financial analysts know nothing about Big Pharma, let alone the likes of ABCAM. IC were saying sell AZN on the basis of pipeline for years, when I was buying between £18-£20 (so was the company). Now they are saying buy, on the basis of the pipeline, and I am selling at £47+ (could get caught out if Pfizer come back, but I believe that their aattention is elsewhere) I think that ABC is geometrically geared to its market place, and that terms like break-even are not relevant to an acquisition like Firefly. It's probably worth it for profile! I bet the management, years ago, on ABC. Tipsters like CR and analysts come and go. If they do drop to 360p again I shall bet the farm (and rich will increase as well) - my Mum will open her purse too. Six months or so later the tipsters will spring out of their boxes:-) apad
apad
Chat Pages: 41  40  39  38  37  36  35  34  33  32  31  30  Older
Your Recent History
LSE
ABC
Abcam
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200227 06:14:10